FDA has continued to exercise its authority, via guidance documents, which FDA says, while not legally enforceable, represent the agencies current thinking on the topic. To further the judicious use
Continue Reading FDA issues guidance #263 recommending that animal-approved over-the-counter medially important antimicrobial drugs are required to be overseen by veterinarians before sale and use.
U.S. Food & Drug Administration (FDA)
FDA issues guidance recommending that animal-approved over-the-counter medically important antimicrobial drugs are required to be overseen by veterinarians before sale and use.
FDA recently published Guidance #263 titled, “Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntarily Bring Under Veterinary Oversight All Products That Continue to …
Continue Reading FDA issues guidance recommending that animal-approved over-the-counter medically important antimicrobial drugs are required to be overseen by veterinarians before sale and use.
Veterinary Medicine, Pet Products and Cannabis
As a veterinarian, if a pet-owner comes to you with questions or concerns about the safety of hemp or CBD infused pet products, are you prepared to navigate the conversation?
Continue Reading Veterinary Medicine, Pet Products and Cannabis
Reposted with Permission “Coronavirus: Animal testing may be best tool to defeat COVID-19|”
by Matthew R. Bailey Originally Published 6:30 a.m. ET April 17, 2020 | Updated 7:06 a.m. ET April 17, 2020
Scientists are working on dozens of potential treatments and vaccines…
COVID 19 Update Telemedicine: Enhanced Tools Available for Veterinarians
FDA has recently announced it is relaxing its enforcement of telemedicine for veterinarians under two federal provisions: (1) when prescribing extralabel drug use; and (2) when prescribing medicate feed pursuant…
Continue Reading COVID 19 Update Telemedicine: Enhanced Tools Available for Veterinarians
Update to FDA’s Guidance #256 on Compounded Animal Drugs
Since we first published “FDA Continues Proposed Extra-Statutory Authority Over Compounded Animal Drugs,” a number of impacted stakeholders have been expressing concern about the intended and unintentional consequences…
Continue Reading Update to FDA’s Guidance #256 on Compounded Animal Drugs
CBD Product Sellers Beware: FDA Issued Warning Letters Claiming Certain CBD Products Are Unapproved New Human and Animal Drugs
On November 25, 2019, FDA posted 15 warning letters from the Center for Food Safety and Applied Nutrition (CFSAN) or the Center for Drug Evaluation and Research (CDER) stating that…
Continue Reading CBD Product Sellers Beware: FDA Issued Warning Letters Claiming Certain CBD Products Are Unapproved New Human and Animal Drugs
FDA Continues Proposed Extra-Statutory Authority Over Compounded Animal Drugs
Without clear statutory authority, FDA has proposed to expand its legal authority over veterinarians and veterinary compounding pharmacies in its newly released “Revised Draft Guidance on Compounding Animal Drugs from…
Continue Reading FDA Continues Proposed Extra-Statutory Authority Over Compounded Animal Drugs
Best Practices for Meat Producers
Beef producers and packers have been required for years to “identify hazard points and critical points during beef slaughtering, which is a necessary first step toward developing a hazard analysis…
Continue Reading Best Practices for Meat Producers
Animal Biotechnology-The Way Forward
On October 30, 2018, the U.S. Food and Drug Administration “announced the Plant and Animal Biotechnology Innovation Action Plan to outline the key priorities the agency will pursue to support…
Continue Reading Animal Biotechnology-The Way Forward